These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6332753)

  • 1. Thyrogastric autoimmunity and MHC associated alleles at the C4 locus in patients with type 1 (insulin-dependent) diabetes.
    McCann VJ; McCluskey J; Kelly H; Kay PH; Zilko PJ; Christiansen FT; Dawkins RL
    Diabetologia; 1984 Jul; 27 Suppl():124-5. PubMed ID: 6332753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.
    Kelly H; McCann VJ; Kay PH; Dawkins RL
    Immunogenetics; 1985; 22(6):643-51. PubMed ID: 3865895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of the fourth component of complement and type 1 (insulin-dependent) diabetes.
    Marcelli-Barge A; Poirier JC; Schmid M; Deschamps I; Lestradet H; Prevost P; Hors J
    Diabetologia; 1984 Jul; 27 Suppl():116-7. PubMed ID: 6332752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.
    McCluskey J; McCann VJ; Kay PH; Zilko PJ; Christiansen FT; O'Neill GJ; Dawkins RL
    Diabetologia; 1983 Mar; 24(3):162-5. PubMed ID: 6573286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class III gene rearrangements in Thai/Chinese supratypes containing null or defective C4 alleles.
    Kay PH; Martin E; Dawkins RL; Charoenwong P
    Immunogenetics; 1988; 27(1):46-50. PubMed ID: 3334723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
    Ferber KM; Keller E; Albert ED; Ziegler AG
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are thyrogastric autoantibodies associated with an increased susceptibility to developing type 1 (insulin-dependent) diabetes? A study in identical twins.
    Johnston C; Millward BA; Leslie RD; Pyke DA; Bottazzo GF
    Autoimmunity; 1990; 6(3):195-201. PubMed ID: 2129777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes.
    Thomsen M; Mølvig J; Zerbib A; de Preval C; Abbal M; Dugoujon JM; Ohayon E; Svejgaard A; Cambon-Thomsen A; Nerup J
    Immunogenetics; 1988; 28(5):320-7. PubMed ID: 3139557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA antigens and complotypes in insulin-dependent diabetes mellitus.
    Partanen J; Koskimies S; Ilonen J; Knip M
    Tissue Antigens; 1986 May; 27(5):291-7. PubMed ID: 3460220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes.
    Rich S; O'Neill G; Dalmasso AP; Nerl C; Barbosa J
    Diabetes; 1985 May; 34(5):504-9. PubMed ID: 3987976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C4 Chido 3 and 6 distinguish two diabetogenic haplotypes: HLA-B49, SC01,DR4,DQw8 and B8,SC01,DR3,DQw2.
    Segurado OG; Giles CM; Iglesias-Casarrubios P; Corell A; Martinez-Laso J; Vicario JL; Arnaiz-Villena A
    Immunobiology; 1991 Sep; 183(1-2):12-22. PubMed ID: 1682241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes.
    Garlepp MJ; Wilton AN; Dawkins RL; White PC
    Immunogenetics; 1986; 23(2):100-5. PubMed ID: 3007340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study.
    de Jongh BM; Bruining GJ; Schreuder GM; Schuurman RK; Radder JK; van Loghem E; Meera Khan P; Hauptmann G; van Rood JJ
    Hum Immunol; 1984 May; 10(1):5-21. PubMed ID: 6586708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC supratypes as markers of null and defective C4 alleles in a Thai/Chinese population: relevance to disease susceptibility.
    Kay PH; Grimsley G; Dawkins RL; Charoenwong P
    Dis Markers; 1987 Mar; 5(1):43-7. PubMed ID: 3502980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC.
    Christiansen FT; Zhang WJ; Griffiths M; Mallal SA; Dawkins RL
    J Rheumatol; 1991 Sep; 18(9):1350-8. PubMed ID: 1757937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes.
    Ziegler R; Alper CA; Awdeh ZL; Castano L; Brink SJ; Soeldner JS; Jackson RA; Eisenbarth GS
    Diabetes; 1991 Jun; 40(6):709-14. PubMed ID: 2040387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
    Skanes V; Larsen B; Sampson-Murphy L; Farid NR
    Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.